Trial intelligence / Profile preview

Sulfadoxine-pyrimethamine plus azithromycin versus sulfadoxine-pyrimethamine alone for malaria prophylaxis in pregnancy

PACTR202305696485090Not yet recruiting

Sponsor
Dr. Robinson Ogwu
Start
May 2023
Modality
Small Molecules
Countries
1
01

Overview

Trial of sulfadoxine + pyrimethamine and azithromycin in malaria (2 arms), sponsored by Dr. Robinson Ogwu. Primary endpoint: Presence of malaria parasites in mother, fetus, and placenta at delivery. Planned start May 2023; status: not yet recruiting.

02

Drugs

sulfadoxine + pyrimethamineazithromycin
03

Conditions

malaria

Beyond the preview

Go deeper on PACTR202305696485090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202305696485090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call